For Healthcare Professionals

Questions?Call 24 hours

1 800 874 6756

Why SUPREP®?

FDA-APPROVED SINCE 2010

THE#1
MOST PRESCRIBED,
BRANDED BOWEL
PREP KIT1

MORE THAN
18 MILLION
SUPREP®BOWEL PREP KITS
DISPENSED SINCE 20101

SUPREP® BOWEL PREP KIT is an effective, split-dose, low-volume osmotic oral sulfate solution indicated for cleansing of the colon as a preparation for colonoscopy in adults and pediatric patients 12 years of age and older.2

award

Braintree Laboratories—trusted makers of quality bowel preparations for over 35 years.

IMPORTANT SAFETY INFORMATION

SUPREP® Bowel Prep Kit (sodium sulfate, potassium sulfate and magnesium sulfate) Oral Solution is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults and pediatric patients 12 years of age and older. DOSAGE AND ADMINISTRATION: Each bottle must be diluted with water to a final volume of 16 ounces (Adults) and 12 ounces (Pediatric patients 12 years of age and older). Must consume additional water after each dose. Stop consumption of all fluids at least 2 hours prior to the colonoscopy. CONTRAINDICATIONS: Use is contraindicated in the following conditions: gastrointestinal (GI) obstruction or ileus, bowel perforation, toxic colitis or toxic megacolon, gastric retention, hypersensitivity to any ingredients in SUPREP Bowel Prep Kit. WARNINGS AND PRECAUTIONS: Risk of fluid and electrolyte abnormalities: Encourage adequate hydration, assess concurrent medications, and consider laboratory assessments prior to and after each use; Cardiac arrhythmias: Consider pre-dose and post-colonoscopy ECGs in patients at increased risk; Seizures: Use caution in patients with a history of seizures and patients at increased risk of seizures, including medications that lower the seizure threshold; Patients with renal impairment or taking medications that affect renal functions: Use caution, ensure adequate hydration and consider laboratory testing; Suspected GI obstruction or perforation: Rule out the diagnosis before administration; Patients at risk for aspiration: Observe during administration. ADVERSE REACTIONS: Most common adverse reactions: Adults: (> 2%) are overall discomfort, abdominal distention, abdominal pain, nausea, and vomiting; Pediatric Patients (>10%) are nausea, abdominal pain, abdominal bloating and vomiting. DRUG INTERACTIONS: Drugs that may increase the risk of fluid and electrolyte abnormalities.

View the Full Prescribing Information and Medication Guide.


References: 1. IQVIA. National Prescription Audit Report. September 2020. 2. SUPREP Bowel Prep Kit [package insert]. Braintree, MA: Braintree Laboratories, Inc; 2020. 3. BowelPrepGuide.com. How to Tell If Your Bowel is Clean Prior to Colonoscopy. https://bowelprepguide.com/how-to-tell-if-your-bowel-is-clean-prior-to-colonoscopy/. Publication date unavailable. Accessed November 17, 2018. 4. American Society of Anesthesiologists Committee on Standards and Practice Parameters. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures. Anesthesiology. 2011;114(3):495-511.